Ozempic side effects and diabetic access: what's actually true

What did @baddestiness actually say?

Here's the honest answer: the video's transcript is largely incoherent. The spoken audio doesn't match the caption at all. The caption, written in French, makes three specific claims: Ozempic is not a game, it has very strong side effects, and people with diabetes need it for their survival, so you should get a prescription. That's actually a reasonable set of points. The transcript itself, however, reads like a garbled transcription of something unrelated, mentioning unemployment rates, tax money, and village planning. So this fact-check will focus on what the caption says, because that's what has 281,000 people reading it.

The caption's core message: don't treat semaglutide casually, respect the side effects, and remember that diabetic patients depend on this drug. That framing is broadly correct, even if it stops short of giving people the clinical detail they'd actually need.

Does the science back this up?

On side effects: yes, the evidence is clear and the creator deserves credit for flagging this. Semaglutide's side effect profile is not trivial. Nausea, vomiting, and diarrhea affect anywhere from 20 to 44 percent of users depending on dose, according to the SUSTAIN and STEP trial series (Wilding et al., 2021, New England Journal of Medicine). More seriously, there are documented cases of gastroparesis, and a 2023 study in JAMA (Sodhi et al.) found that GLP-1 receptor agonists were associated with significantly higher rates of pancreatitis and bowel obstruction compared to bupropion-naltrexone in a population of patients without diabetes.

On diabetics needing it for survival: this is where things get more nuanced. Ozempic (semaglutide 1mg and 2mg) is FDA-approved for type 2 diabetes management, and it does more than lower blood sugar. The SUSTAIN-6 trial (Marso et al., 2016, NEJM) showed it reduced major cardiovascular events by 26 percent in high-risk type 2 diabetic patients. For some people, this drug is genuinely life-extending, not just weight-managing.

What did they get wrong (or right)?

They got the tone right and the facts mostly right, which puts this creator ahead of most GLP-1 content on TikTok. The phrase that Ozempic "n'est pas un jeu" is one of the more responsible things said about this drug in short-form video format.

What's missing is specificity. Saying side effects are "very very strong" without naming them is vague enough to be unhelpful. Are we talking about nausea that passes in two weeks, or are we talking about the rare but real risk of thyroid C-cell tumors flagged in Ozempic's black box warning? Those are very different conversations.

The survival framing for diabetic patients is also a slight overstatement for the average type 2 patient, though it holds up for those with established cardiovascular disease. Insulin, metformin, and other agents remain first-line for many diabetics. Semaglutide is important, sometimes essential, but calling it a survival drug universally oversimplifies the prescribing picture.

The call to get a prescription is correct. Full stop.

What should you actually know?

Semaglutide, whether branded as Ozempic or Wegovy, is a serious pharmaceutical with a real risk profile and genuine therapeutic value. The STEP 1 trial (Wilding et al., 2021, NEJM) showed 14.9 percent average body weight reduction in adults with obesity over 68 weeks, but participants also had a 44 percent rate of gastrointestinal adverse events. That tradeoff deserves informed consent, not a TikTok caption.

• GLP-1 shortages have been a documented problem. The FDA listed semaglutide on its drug shortage list in 2022 and 2023, and this has real consequences for diabetic patients who were prescribed it before the weight-loss wave hit.
• Compounded semaglutide is not the same as Ozempic or Wegovy. Formulation, dosing precision, and purity standards differ. Do not assume equivalency.
• If you are considering GLP-1 therapy for weight management, a licensed clinician needs to evaluate your cardiovascular history, thyroid history, and current medications. This is not optional due diligence.

The bottom line

@baddestiness is saying something true and responsible in a space full of people doing the opposite. The warning about side effects and the insistence on prescriptions are exactly right. The caption would earn a passing grade in a public health communication class. The spoken video content, at least as transcribed, is another matter entirely and appears to have no connection to the topic. Evaluate the caption. Get the prescription. Talk to a clinician who has actually read the label.